Stockhub

Hemostemix Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 September 2022

  • curprev 03:1103:11, 21 September 2022 95.149.241.133 talk 796 bytes +796 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the Unit..."
Retrieved from "https://stockhub.co/research/Hemostemix_Inc."